Niki Sprinzen was quoted in an Anti-Corruption Report discussing the settlement agreement Novartis, a Swiss pharmaceutical company, reached with the U.S. DOJ and the SEC to settle FCPA charges. Ultimately, “a company’s enforcement history and resolutions with other enforcement agencies play into the form and size of a resolution,” said Niki.
To read more of this article, click here. (subscription required)